Hamel T, Rheault J, Simonyan D, et al. - Researchers conducted this retrospective case-control study to evaluate the protective effect of implanting a blue light-filtering intraocular lens (IOL) on neovascular age-related macular degeneration (AMD) development. Case patients were diagnosed with and treated for wet AMD, and they had previously implanted IOLs at least 3 years prior to the diagnosis of wet AMD. Control patients were chosen at random from among those who had cataract surgery at the institution. There were no correlations found between the presence of a blue light filter in the IOL and the occurrence of wet AMD. Patients with AMD who did not have a blue light-filtering IOL were injected significantly later than those who did have a blue light-filtering IOL, contradicting the potential clinical benefit of the blue light filter.